The CD47 pathway was successfully blocked with mouse antibodies [15], humanized antibodies [17] or completely human antibodies [18] against CD47 antigen that resulted in blocking tumor growth using cancer cell line and patient-derived xenograft mouse models [11]. Here, CD47 is linked to cancer.